Stock Report

Jagsonpal Pharmaceuticals Ltd Q4 FY2025 PAT slides QoQ to Rs. 6.58 crores



Posted On : 2025-05-06 19:14:30( TIMEZONE : IST )

Jagsonpal Pharmaceuticals Ltd Q4 FY2025 PAT slides QoQ to Rs. 6.58 crores

has reported Standalone financial results for the period ended March 31, 2025.

Financial Results (Q4 FY2025) - QoQ Comparison

The company has reported total income of Rs. 61.330 crores during the period ended March 31, 2025 as compared to Rs. 76.347 crores during the period ended December 31, 2024.

The company has posted net profit / (loss) of Rs. 6.583 crores for the period ended March 31, 2025 as against net profit / (loss) of Rs. 31.990 crores for the period ended December 31, 2024.

The company has reported EPS of Rs. 0.98 for the period ended March 31, 2025 as compared to Rs. 4.74 for the period ended December 31, 2024.

Financials Q4 FY2025 Q3 FY2025 % Change
Total Income ₹ 61.330 crs ₹76.347 crs Up Tick / Down Tick-19.67%
Net Profit ₹6.583 crs ₹31.990 crs Up Tick / Down Tick-79.42%
EPS ₹0.98 ₹4.74 Up Tick / Down Tick-79.32%

Financial Results (Q4 FY2025) - YoY Comparison

The company has reported total income of Rs. 61.330 crores during the period ended March 31, 2025 as compared to Rs.45.973 crores during the period ended March 31, 2024.

The company has posted net profit / (loss) of Rs.6.583 crores for the period ended March 31, 2025 as against net profit / (loss) of Rs.3.549 crores for the period ended March 31, 2024.

The company has reported EPS of Rs.0.98 for the period ended March 31, 2025 as compared to Rs.0.54 for the period ended March 31, 2024.

Financials Q4 FY2025 Q4 FY2024 % Change
Total Income ₹ 61.330 crs ₹45.973 crs Up Tick / Down Tick33.40%
Net Profit ₹6.583 crs ₹3.549 crs Up Tick / Down Tick85.49%
EPS ₹0.98 ₹0.54 Up Tick / Down Tick81.48%

Financial Results (Year Ended FY2025) - YoY Comparison

The company has reported total income of Rs.276.906 crores during the Financial Year ended March 31, 2025 as compared to Rs.217.981 crores during the Financial Year ended March 31, 2024.

The company has posted net profit / (loss) of Rs.55.361 crores for the Financial Year ended March 31, 2025 as against net profit / (loss) of Rs.22.463 crores for the Financial Year ended March 31, 2024.

The company has reported EPS of Rs.8.22 for the Financial Year ended March 31, 2025 as compared to Rs.3.39 for the Financial Year ended March 31, 2024.

Financials Year Ended FY2025 Year Ended FY2024 % Change
Total Income ₹276.906 crs ₹217.981 crs Up Tick / Down Tick27.03%
Net Profit ₹55.361 crs ₹22.463 crs Up Tick / Down Tick146.45%
EPS ₹8.22 ₹3.39 Up Tick / Down Tick142.48%

Source : Equity Bulls

Keywords

JagsonpalPharmaceuticals Q4FY25 Q4FY2025 FY2025 ResultUpdate